Topics Comments
 < Previous page    Next page > 
Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
CSPC Pharmaceutical Group Limited 2020-05-01T15:19 財經茄呢啡 石藥集團升２．２９％報１６．０８元，表現最佳；金沙升２．１７％報３３元；昨天發布業績的匯控升０．２５％報４０．０５元。
CSPC Pharmaceutical Group Limited 2020-05-01T15:19 財經茄呢啡 萬州國際下滑４．５９％，表現墊底。醫藥股跌幅居前，中國生物制藥和石藥集團各跌１．９％和２．０４％。博彩股亦表現不振，銀河娛樂及金沙中國各跌０．４９％和１．２４％。
CSPC Pharmaceutical Group Limited 2020-05-01T15:19 財經茄呢啡 熱炒的醫藥股捱沽，石藥集團及中國生物制藥收市跌２％及１．９％。平安好醫生回吐５．８％；阿里健康跌１．２％。
CSPC Pharmaceutical Group Limited 2020-04-24T15:12 財經茄呢啡 在被恆生指數公司以６．８３％的權重納入「恆生滬深港創新藥精選５０指數」後，作為大藍籌股創新藥龍頭的石藥集團再度公布業績利好。
CSPC Pharmaceutical Group Limited 2020-04-24T15:12 財經茄呢啡 藥業股個別發展，昨日大幅下跌的中生制藥升０．７３％ ; 報１１．０２元，為表現最佳藍籌股 ; 石藥集團跌２．４％，報１５．４４元 ; 藥明生物跌１．１８％，報１１７．１元 ; 藥明康德跌０．９１％，報１０８．４元 ; 威高股權升１．５３％，報１１．９２元; 聯邦制藥升１．７７％，報６．９２元 ; 微創醫療升１．６４％，報１７．３８元。
CSPC Pharmaceutical Group Limited 2020-04-24T15:12 財經茄呢啡 中生制藥升２．１７％，報１１．３２元 ; 石藥集團升０．１３％，報１５．８４元 ;麗珠醫藥升２．３７％，報３４．５５元 ; 神滅藥業升２．１２％，報５．７９元 ; 三生制藥升１．４５％，報８．３９元。
CSPC Pharmaceutical Group Limited 2020-04-17T14:51 財經茄呢啡 石藥集團早在２０１２年就開啟了恩悉的立項研究，於２０１９年１２月２６日得到了國家藥品監督管理局頒發的藥品注冊批件。石藥集團後續還將開展更多新藥的開發，助力我國帕金森病治療領域的發展，以更好的產品品質，更符合中國國情的價錢，讓更多新藥惠及廣大患者。
CSPC Pharmaceutical Group Limited 2020-03-13T15:37 財經茄呢啡 ２００６年，中國開始引入阿比多爾。依據中國國家藥品監督管理局資料，現在可以生產阿比多爾的企業包括：江蘇吳中醫藥集團、江蘇漣水制藥、石家莊四藥、石藥集團歐意藥業、海南先聲藥業及石家莊中碩制藥。
CSPC Pharmaceutical Group Limited 2020-03-13T15:37 財經茄呢啡 ●石藥集團開發「利伐沙班片(１０ＭＧ)」已獲中國藥監局頒發藥品注冊批件，為該抗凝藥於國內第二間獲批的仿制藥。
CSPC Pharmaceutical Group Limited 2020-02-28T14:46 財經茄呢啡 高端創新藥龍頭石藥集團是內地領先高端創新藥龍頭，近年來以腫瘤與心腦血管為主的創新藥板塊快速提升，２０１９年１~３季度創新藥占收入比例已經提升從２０１５年３３．１％增長到２０１９年１-３Ｑ約９７％。２０１７年以前石藥集團的創新藥以心腦血管藥物為主，但是２０１８年與２０１９年腫瘤藥銷售提升數倍，公司成為腫瘤與心腦血管創新藥行業的龍頭。
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.